These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 12020188)

  • 1. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
    Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
    Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cessation of oral anticoagulants in antiphospholipid syndrome.
    Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
    Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of thrombosis in the antiphospholipid-antibody syndrome.
    Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
    N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
    Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
    Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
    Rosove MH; Brewer PM
    Ann Intern Med; 1992 Aug; 117(4):303-8. PubMed ID: 1637025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
    Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
    Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity of anticoagulation in the treatment of thrombosis in the antiphospholipid syndrome: a meta-analysis.
    Silva FF; Carvalho JF
    Rev Bras Reumatol; 2015; 55(2):159-66. PubMed ID: 25440707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment.
    Castellino G; Cuadrado MJ; Godfrey T; Khamashta MA; Hughes GR
    Ann Rheum Dis; 2001 May; 60(5):527-30. PubMed ID: 11302880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of anticoagulation in patients with low risk antiphospholipid syndrome.
    Bakow BR; Phung Q; Rabinovich D; Olszewski AJ; Reagan JL
    J Thromb Thrombolysis; 2023 Jul; 56(1):121-127. PubMed ID: 37219825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
    Ordi-Ros J; Sáez-Comet L; Pérez-Conesa M; Vidal X; Riera-Mestre A; Castro-Salomó A; Cuquet-Pedragosa J; Ortiz-Santamaria V; Mauri-Plana M; Solé C; Cortés-Hernández J
    Ann Intern Med; 2019 Nov; 171(10):685-694. PubMed ID: 31610549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
    Bazzan M; Vaccarino A; Stella S; Sciascia S; Montaruli B; Bertero MT; Carignola R; Roccatello D;
    Lupus; 2016 Apr; 25(5):479-85. PubMed ID: 26657216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation in the antiphospholipid syndrome.
    Casais P; Alberto MF; Gennari LC; Grosso SH; Meschengieser SS; Lazzari MA
    Haematologica; 2004 Apr; 89(4):503-4. PubMed ID: 15075090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation: an 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia.
    Ames PR; Ciampa A; Margaglione M; Scenna G; Iannaccone L; Brancaccio V
    Thromb Haemost; 2005 Apr; 93(4):694-9. PubMed ID: 15841314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher?
    Baquero-Salamanca M; Téllez-Arévalo AM; Calderon-Ospina C
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25858939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of patients receiving long-term fondaparinux for thrombotic antiphospholipid syndrome.
    Bor B; Doyle AJ; Bartoli-Abdou JK; Hackett A; Collings V; Omrani F; Foskett C; Wareing A; Young J; Breen KA; Hunt BJ
    Lupus; 2024 Nov; 33(13):1446-1454. PubMed ID: 39283750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
    Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
    J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.